Case Report: Cerebellar ataxia with serum anti-GluK2 positivity and a multiple system atrophy–like phenotype: a longitudinal diagnostic dilemma

Anti-GluK2 antibody–associated neurologic disease is a rare neuronal antibody–associated syndrome that frequently involves the cerebellum, but its long-term clinical evolution remains poorly defined. We report a 53-year-old woman who initially presented predominantly with cerebellar ataxia. Brain MRI showed cerebellar atrophy and a hot cross bun sign. Serum anti-GluK2 IgG was detected twice, whereas cerebrospinal fluid (CSF) testing remained negative. Routine CSF studies and tumor screening were unremarkable, and genetic testing for hereditary ataxia identified no explanatory findings. Her gait improved following two courses of intravenous methylprednisolone pulse therapy, and an immune-mediated cerebellar syndrome remained the favored working diagnosis. During follow-up, anti-GluK2 antibodies became undetectable; however, ataxia subsequently worsened, accompanied by dysarthria, progressive cerebellar atrophy, bilateral middle cerebellar peduncle abnormalities, orthostatic hypotension, and increased postvoid residual urine volume. An exploratory serum quiescent seed amplification assay was positive, indicating α-synuclein seeding activity in the tested sample. These findings further increased clinical suspicion of multiple system atrophy of the cerebellar type (MSA-C). This case highlights the longitudinal challenges in distinguishing neuronal antibody-associated cerebellar ataxia from MSA-C-like neurodegeneration and underscores the need to reassess initial diagnoses as clinical, imaging, and laboratory evidence accumulates.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-11-16
DOI
https://doi.org/10.3389/fimmu.2026.1974711
Primary Topic
Autoimmune Neurological Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Case Report: Cerebellar ataxia with serum anti-GluK2 positivity and a multiple system atrophy–like phenotype: a longitudinal diagnostic dilemma

Zunjing Liu, Cong Lu, Min Cheng, Liuchang He
1 links
Frontiers in Immunology
Autoimmune Neurological Disorders and Treatments
article

Case Report: Cerebellar ataxia with serum anti-GluK2 positivity and a multiple system atrophy–like phenotype: a longitudinal diagnostic dilemma

Zunjing Liu, Cong Lu, Min Cheng, Liuchang He
article en

Abstract

Anti-GluK2 antibody–associated neurologic disease is a rare neuronal antibody–associated syndrome that frequently involves the cerebellum, but its long-term clinical evolution remains poorly defined. We report a 53-year-old woman who initially presented predominantly with cerebellar ataxia. Brain MRI showed cerebellar atrophy and a hot cross bun sign. Serum anti-GluK2 IgG was detected twice, whereas cerebrospinal fluid (CSF) testing remained negative. Routine CSF studies and tumor screening were unremarkable, and genetic testing for hereditary ataxia identified no explanatory findings. Her gait improved following two courses of intravenous methylprednisolone pulse therapy, and an immune-mediated cerebellar syndrome remained the favored working diagnosis. During follow-up, anti-GluK2 antibodies became undetectable; however, ataxia subsequently worsened, accompanied by dysarthria, progressive cerebellar atrophy, bilateral middle cerebellar peduncle abnormalities, orthostatic hypotension, and increased postvoid residual urine volume. An exploratory serum quiescent seed amplification assay was positive, indicating α-synuclein seeding activity in the tested sample. These findings further increased clinical suspicion of multiple system atrophy of the cerebellar type (MSA-C). This case highlights the longitudinal challenges in distinguishing neuronal antibody-associated cerebellar ataxia from MSA-C-like neurodegeneration and underscores the need to reassess initial diagnoses as clinical, imaging, and laboratory evidence accumulates.

Frontiers in ImmunologyVol. 17
Peking University People's Hospital (CN)
Good health and well-being
Autoimmune Neurological Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon